Parallax Volatility Advisers’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Parallax Volatility Advisers’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,806	Closed	-$44K	–	5295
2017 Q4	$44K	Buy	+1,806	New	+$34.7K	﹤0.01%	3293

Parallax Volatility Advisers's ENTL Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 1,806 shares — an estimated $44K sold.

Parallax Volatility Advisers first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $44K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Parallax Volatility Advisers reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 1,806 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $44K.
Parallax Volatility Advisers first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
Parallax Volatility Advisers's Entellus Medical, Inc. Common Stock position peaked at $44K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.